ERCC4 and cancer: As a crucial rate-limiting factor in NER, the low expression of XPF acted as a genetic susceptibility factor in the development of cancers and a prognosis risk factor after chemotherapy in several of cancers, including esophageal cancer [15], [23], [24], [25].